Study Phase 3

A Double-Blind, Randomized, Multi-Center, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Single Dose of a 500-mg Chewable Tablet of Mebendazole in the Treatment of Soil-Transmitted Helminth Infections (Ascaris Lumbricoides and Trichuris Trichiura) in Pediatric Subjects

Trial Information

Generic NameMebendazoleProduct NameVERMOXTherapeutic AreaParasitic DiseasesEnrollment295% Female51.5%% WhiteN/A
Product ClassAntiparasiticsSponsor Protocol NumberMEBENDAZOLGAI3003Data PartnerJohnson & JohnsonCondition StudiedHelminth InfectionsMean/Median Age (Years)7.8

Supporting Documentation

  • Collected Datasets Available
  • Data Definition Specification Available
  • Protocol with Amendments Available
  • Clinical Study Report Available

Approved Data Requests Associated with this Trial


Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.